PARKINSON

Clinical trials for PARKINSON explained in plain language.

Never miss a new study

Get alerted when new PARKINSON trials appear

Sign up with your email to follow new studies for PARKINSON, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 5 Not yet recruiting 2 Not yet finished but already full! 2 Completed 5 Terminated 1

Parkinson's drug side effect targeted by antioxidant NAC – but trial stalls

Symptom relief Terminated

This study tested whether N-acetylcysteine (NAC), an antioxidant, could help reduce impulse control disorders caused by Parkinson's medications. Only 14 people with mild-to-moderate symptoms were enrolled before the trial was stopped early. The goal was to see if 10 weeks of NAC …

Matched conditions: PARKINSON

Phase: PHASE3 • Sponsor: Centre Hospitalier Universitaire, Amiens • Aim: Symptom relief

Last updated Jun 27, 2026 13:07 UTC

PARKINSON

Get alerted when new PARKINSON trials appear

Parkinson's drug side effect targeted by antioxidant NAC – but trial stalls